ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102225 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102225; 2) Community: the network communities that were significantly associated with the response to NSC 102225; 3) Molecule: the relationships between components within communities and NSC 102225; 4) MDR: the compounds that were significantly associated with the NSC 102225.

NSC Compound Enrichment Correlation
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.00485717408280859 0.47066637
NSC 762346 Null 0.00485717408280859 0.33165246
NSC 87864 N-Salicylidene-N-salicyloylhydrazine 0.00485717408280859 0.27601068
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0048681766467277 0.33719678
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0048681766467277 0.30784894
NSC 382046 Null 0.0048681766467277 0.41937956
NSC 617989 3-Deazaneplanocin, hydrochloride 0.0048681766467277 0.47327511
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.0048681766467277 0.37866784
NSC 628297 Null 0.0048681766467277 0.1670587
NSC 634037 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazine 0.0048681766467277 0.42478924
Total:118  Current:22    [First] [Prev] [Next] [Last]